Literature DB >> 30670876

Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.

Pakawat Chongsathidkiet1,2,3, Christina Jackson4, Shohei Koyama5, Franziska Loebel6, Xiuyu Cui1,2, S Harrison Farber1,2,7, Karolina Woroniecka1,2,3, Aladine A Elsamadicy1,2, Cosette A Dechant1,2, Hanna R Kemeny1,2, Luis Sanchez-Perez1,2, Tooba A Cheema8, Nicholas C Souders9, James E Herndon10, Jean-Valery Coumans11, Jeffrey I Everitt3, Brian V Nahed11, John H Sampson1,2,3,12,13, Michael D Gunn3,13,14, Robert L Martuza11, Glenn Dranoff15, William T Curry11, Peter E Fecci16,17,18.   

Abstract

In the version of this article originally published, the figure callout in this sentence was incorrect: "Furthermore, in S1P1-KI mice themselves, whereas PD-1 blockade was ineffectual as monotherapy, the effects of 4-1BB agonism and checkpoint blockade proved additive, with the combination prolonging median survival and producing a 50% long-term survival rate (Fig. 6f)." The callout should have been to Supplementary Fig. 6b. The error has been corrected in the PDF and HTML versions of the article.

Entities:  

Year:  2019        PMID: 30670876      PMCID: PMC6825406          DOI: 10.1038/s41591-019-0355-0

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  3 in total

Review 1.  The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC.

Authors:  Ji Li; Min Wang; Shuhui Xu; Yuying Li; Jiatong Li; Jinming Yu; Hui Zhu
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

2.  Myeloid cell subsets that express latency-associated peptide promote cancer growth by modulating T cells.

Authors:  Galina Gabriely; Duanduan Ma; Shafiuddin Siddiqui; Linqing Sun; Nathaniel P Skillin; Hadi Abou-El-Hassan; Thais G Moreira; Dustin Donnelly; Andre P da Cunha; Mai Fujiwara; Lena R Walton; Amee Patel; Rajesh Krishnan; Stuart S Levine; Brian C Healy; Rafael M Rezende; Gopal Murugaiyan; Howard L Weiner
Journal:  iScience       Date:  2021-10-27

3.  Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.

Authors:  Shiao-Pei Weathers; Marta Penas-Prado; Katayoun Rezvani; Amy B Heimberger; Be-Lian Pei; Xiaoyang Ling; Cynthia Kassab; Pinaki Banerjee; Mustafa Bdiwi; Hila Shaim; Abdullah Alsuliman; Mayra Shanley; John F de Groot; Barbara J O'Brien; Rebecca Harrison; Nazanin Majd; Carlos Kamiya-Matsuoka; Gregory N Fuller; Jason T Huse; Linda Chi; Ganesh Rao; Jeffrey S Weinberg; Frederick F Lang; Raymond Sawaya; Elizabeth J Shpall
Journal:  Clin Cancer Res       Date:  2020-04-16       Impact factor: 13.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.